review Open AccessTop 1% cited
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Cell Metabolism · 2013 · Vol. 17(6) · pp. 819–837
Jonathan E. Campbell✉(Mount Sinai Hospital)Daniel J. Drucker(Mount Sinai Hospital)
Diabetes Treatment and ManagementReceptor Mechanisms and SignalingPancreatic function and diabetesIncretinHormoneReceptorGlucagon-like peptide-1BiologyType 2 diabetesBioinformaticsEndocrinologyMedicineInternal medicine
MeSH terms
AnimalsGastric Inhibitory PolypeptideHumansIslets of LangerhansReceptors, Gastrointestinal HormoneSignal TransductionMiceGlucagon-Like Peptide 1Incretins
Funding
- Canada Research Chairs
- Canadian Institutes of Health Research
Citations
1,426
FWCI
70.13
field-weighted impact
References
154
Percentile
100%
vs. same field & year
Citations per year
Cited by
Adipokines in health and disease
Trends in Pharmacological Sciences · 2015 · 1,005 citations
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 2018 · 1,752 citations
References
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Nature Genetics · 2006 · 2,266 citations
Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
Journal of Neuroscience Research · 2003 · 342 citations
The biology of incretin hormones
Cell Metabolism · 2006 · 2,140 citations
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Molecular Endocrinology · 2003 · 479 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
